 | Up a level |
Rezaieyazdi, Z. and Farooqi, A. and Soleymani-Salehabadi, H. and Ahmadzadeh, A. and Aslani, M. and Omidian, S. and Sadoughi, A. and Vahidi, Z. and Khodashahi, M. and Zamurrad, S. and Mortazavi-Jahromi, S. S. and Fallahzadeh, H. and Hosseini, M. and Aghazadeh, Z. and Ekhtiari, P. and Matsuo, H. and Rehm, B. H. A. and Cuzzocrea, S. and D’Aniello, A. and Mirshafiey, A. (2019) International multicenter randomized, placebo-controlled phase III clinical trial of β-d-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology, 27 (5). pp. 911-921.
